101975-15-9 Usage
Uses
Used in Pharmaceutical Industry:
4'-(1,1,2,2-TETRAFLUOROETHOXY)ACETOPHENONE is used as a key intermediate for the synthesis of various pharmaceuticals, leveraging its reactivity to form complex organic compounds with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 4'-(1,1,2,2-TETRAFLUOROETHOXY)ACETOPHENONE is utilized as a precursor in the production of agrochemicals, contributing to the development of effective pesticides and other agricultural products.
Used in Organic Chemistry Research:
4'-(1,1,2,2-TETRAFLUOROETHOXY)ACETOPHENONE is employed as a valuable building block in organic chemistry, where it is instrumental in the exploration of new synthetic pathways and the creation of novel compounds with unique properties.
Used in the Development of Synthetic Methodologies:
4'-(1,1,2,2-TETRAFLUOROETHOXY)ACETOPHENONE is used as a reagent in the advancement of synthetic methodologies, providing a foundation for more efficient and innovative chemical synthesis processes.
Check Digit Verification of cas no
The CAS Registry Mumber 101975-15-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,1,9,7 and 5 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 101975-15:
(8*1)+(7*0)+(6*1)+(5*9)+(4*7)+(3*5)+(2*1)+(1*5)=109
109 % 10 = 9
So 101975-15-9 is a valid CAS Registry Number.
101975-15-9Relevant academic research and scientific papers
Synthesis and discovery of 2,3-dihydro-3,8-diphenylbenzo[1,4]oxazines as a novel class of potent cholesteryl ester transfer protein inhibitors
Wang, Aihua,Prouty, Catherine P.,Pelton, Patricia D.,Yong, Maria,Demarest, Keith T.,Murray, William V.,Kuo, Gee-Hong
scheme or table, p. 1432 - 1435 (2010/07/06)
2,3-Dihydro-3,8-diphenylbenzo[1,4]oxazines were identified as a new class of potent cholesteryl ester transfer protein inhibitors. The most potent compound 6a (IC50 = 26 nM) possessed a favorable pharmacokinetic profile with good oral bioavailability in rat (F = 53%) and long human liver microsome stability (t1/2 = 62 min). It increased HDL-C in human CETP transgenic mice and high-fat fed hamsters. The structure and activity relationship of this series will be described in this Letter.
